Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease
<b>Background/Objectives</b>: Hypertriglyceridemia (HTG) is a common multifactorial metabolic disorder often with genetic predisposition. Multiple lines of evidence support a causal role of triglyceride-rich lipoproteins (TRLs) in atherosclerotic cardiovascular disease (ASCVD), with severe HTG leadi...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-08-01
|
| Serija: | Pharmaceutics |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1999-4923/17/9/1107 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|